Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023 - PowerPoint PPT Presentation

1 / 6
} ?>
View by Category
About This Presentation
Title:

Diabetic Retinopathy Market share to reach USD 11.1 billion by 2023

Description:

Get more information @ Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others. – PowerPoint PPT presentation

Number of Views:33

less

Write a Comment
User Comments (0)
About PowerShow.com